Clinical trial
A Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
NCT07206121 is registered in ClinicalTrials.gov with Innoblative Designs, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
- Lead sponsor
- Innoblative Designs, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 10, 2026
- Completion date
- February 6, 2032
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, breast cancer - infiltrating ductal carcinoma, breast-conserving surgery, er/pr+her2neu, grade i, ii, iii